Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WP10 follow-up safety trial of enalapril orodispersible minitablets in children with chronic heart failure
NL-OMON46324Phase 2Active, not recruiting
- Sponsor
- Ethicare Clinical Trial Services
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of enalapril in chronic heart failure (CHF), sponsored by Ethicare Clinical Trial Services. Primary endpoint: Adverse events. Started Mar 2016; status: active, not recruiting.
02
Drugs
enalapril
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NL-OMON46324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46324.